Novartis Ag (NVSEF) Profit After Tax Growth (5y) (2014 - 2025)

Novartis Ag (NVSEF) Profit After Tax Growth (5y) (2014 - 2025) Analysis & Trends

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Eli Lilly	1,066.16 Bn	1,060.88 Bn	16.22 Bn
2	Johnson & Johnson	611.69 Bn	589.64 Bn	15.96 Bn
3	AbbVie	444.34 Bn	434.99 Bn	10.78 Bn
4	Astrazeneca	284.94 Bn	277.05 Bn	12.61 Bn
5	Merck	224.23 Bn	218.58 Bn	12.09 Bn
6	Amgen	195.12 Bn	183.08 Bn	5.87 Bn
7	Gilead Sciences	156.45 Bn	148.73 Bn	5.52 Bn
8	Pfizer	136.01 Bn	123.24 Bn	-1.21 Bn
9	Novartis Ag	113.45 Bn	113.67 Bn	-
10	Novartis Ag	-	-	-

Historic Data

Download Data

Date	Value
Jun 30, 2025	16.60%
Dec 31, 2024	23.54%
Sep 30, 2024	12.02%
Jun 30, 2024	-13.75%
Mar 31, 2024	10.37%
Dec 31, 2023	19.74%
Sep 30, 2023	-1.81%
Jun 30, 2023	5,782.28%
Mar 31, 2023	3.75%
Dec 31, 2022	-98.73%
Sep 30, 2022	-98.73%
Jun 30, 2022	-3.05%
Mar 31, 2022	-3.67%
Dec 31, 2021	39.55%
Sep 30, 2021	6,938.28%
Jun 30, 2021	8,166.42%
Mar 31, 2021	43,993.83%
Dec 31, 2020	15.90%
Sep 30, 2020	2.57%
Jun 30, 2020	7,452.07%